Circio Holding Balance Sheet Health
Financial Health criteria checks 0/6
Circio Holding has a total shareholder equity of NOK-43.2M and total debt of NOK35.0M, which brings its debt-to-equity ratio to -81.1%. Its total assets and total liabilities are NOK7.5M and NOK50.7M respectively.
Key information
-81.1%
Debt to equity ratio
NOK 35.00m
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 2.84m |
| Equity | -NOK 43.16m |
| Total liabilities | NOK 50.65m |
| Total assets | NOK 7.49m |
Recent financial health updates
Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?
Jul 08
Is Targovax (OB:TRVX) Using Debt In A Risky Way?
Oct 27Is Targovax (OB:TRVX) A Risky Investment?
Jul 05Is Targovax (OB:TRVX) Using Debt In A Risky Way?
Feb 20Recent updates
Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year
May 29Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price
Aug 24Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?
Jul 08Is Targovax (OB:TRVX) Using Debt In A Risky Way?
Oct 27Is Targovax (OB:TRVX) A Risky Investment?
Jul 05Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now
Mar 10Is Targovax (OB:TRVX) Using Debt In A Risky Way?
Feb 20The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares
Dec 05
Financial Position Analysis
Short Term Liabilities: CRNA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: CRNA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: CRNA has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: CRNA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: CRNA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if CRNA's interest payments on its debt are well covered by EBIT.